NCT03089073View on ClinicalTrials.gov

Study of Minirin Melt® in Adult Patients With Nocturia

TerminatedOBSERVATIONAL
Enrollment

835

Participants

Timeline

Start Date

July 13, 2015

Primary Completion Date

October 5, 2018

Study Completion Date

October 5, 2018

Conditions
Nocturia
Interventions
DRUG

Desmopressin

60μg or 120μg once daily at bedtime

Trial Locations (1)

Unknown

Daegu Fatima Hospital (there may be other sites in this country), Daegu

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT03089073 - Study of Minirin Melt® in Adult Patients With Nocturia | Biotech Hunter | Biotech Hunter